Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | 2M | 515,000 | 11M | 299,000 |
| Cost of revenue | 835,000 | 2M | 2M | 400,000 |
| Gross profit | 2M | −1M | 9M | −101,000 |
| Research and development | 8M | 11M | 10M | 10M |
| Selling, general and administrative | 5M | 6M | 6M | 7M |
| Operating income | −11M | −17M | −8M | −17M |
| Net income | −11M | −17M | −7M | −17M |
| Earnings per share | −0.94 | −1.45 | −0.62 | −1.53 |
| Earnings per share, diluted | −0.94 | −1.45 | −0.62 | −1.53 |
| Weighted average shares | 12M | 11M | 11M | 11M |
| Weighted average shares, diluted | 12M | 11M | 11M | 11M |
| Metric | 18 Aug 2026 | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | — | 6M | 12M | 27M | 30M | 13M |
| Receivables | — | 1,000 | 150,000 | — | — |
| Metric | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Operating cash flow | −9M | −14M | −3M | −14M |
| Depreciation and amortisation | 912,000 | 1M | 1M | 1M |
| Share-based compensation | 999,000 | 2M | 2M | 2M |
| Capital expenditure |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| Inventory | — | 573,000 | 440,000 | 714,000 | — | — |
| Current assets | — | 7M | 13M | 28M | — | — |
| Property, plant and equipment | — | 1M | 2M | 3M | — | — |
| Total assets | — | 11M | 19M | 34M | — | — |
| Current liabilities | — | 3M | 3M | 3M | — | — |
| Total liabilities | — | 5M | 5M | 6M | — | — |
| Equity | — | 6M | 13M | 28M | 32M | 45M |
| Shares outstanding | — | 13M | 11M | 11M | — | — |
| Shares issued | — | 13M | 11M | 11M | — | — |
| 28,000 |
| 483,000 |
| 954,000 |
| 1M |
| Investing cash flow | −27,000 | −539,000 | −1M | 29M |
| Financing cash flow | 3M | 9,000 | 1M | 2M |